Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
3.9
Journals
JCM
Special Issues
Clinical Advances in Plastic and Aesthetic Surgery
share announcement

Clinical Advances in Plastic and Aesthetic Surgery

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Plastic, Reconstructive and Aesthetic Surgery/Aesthetic Medicine".

Deadline for manuscript submissions: closed (25 September 2023) | Viewed by 7237

Special Issue Editor

Dr. Carlo M. Oranges

E-Mail Website
Guest Editor
Department of Plastic, Reconstructive and Aesthetic Surgery, Geneva University Hospitals, Geneva University, 1205 Geneva, Switzerland
Interests: plastic surgery; aesthetic surgery; reconstructive surgery; microsurgery; breast surgery; fat grafting; regenerative surgery

Special Issue Information

Dear Colleagues,

During the past few decades, plastic surgery has experienced tremendous advancements. New techniques have been introduced while new data allow a better understanding of procedures already established. In particular, recently introduced microsurgical options have provided a larger spectrum of free flaps available to permit a more tailored reconstruction, while new technologies have been implemented to allow better flap surveillance and minimize necrosis. New techniques, also possibly combined with newly developed materials, have also permitted easier solutions to complex reconstructive challenges. In the context of aesthetic surgery, new trends have been observed with some procedures gaining increased popularity, such as labia minora reduction and gluteal augmentation. Conversely, well-established procedures have been further developed to ensure better outcomes. Substantial advances have also been made in the fields of burn treatments and in the understanding and treatment of oncologic diseases of plastic surgery interest. The aim of this Special Issue is to present recent advances in the field of plastic, reconstructive, and aesthetic surgery. Therefore, researchers in the field of plastic surgery are invited to submit original articles or reviews to this Special Issue (case reports and short reviews are not accepted).

Dr. Carlo M. Oranges
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • plastic surgery
  • aesthetic surgery
  • reconstructive surgery
  • microsurgery
  • breast surgery
  • fat grafting
  • regenerative surgery

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

8 pages, 996 KiB  
Article
Spiradenocarcinoma: SEER Study of Epidemiology, Survival, and Treatment Options
by Jérôme Martineau, Solange N. Walz, Matteo Scampa, Salvatore Giordano, Daniel F. Kalbermatten and Carlo M. Oranges
J. Clin. Med. 2023, 12(5), 2045; https://doi.org/10.3390/jcm12052045 - 4 Mar 2023
Cited by 2 | Viewed by 1289
Abstract
(1) Background: Spiradenocarcinoma is an extremely rare malignant adnexal tumor and there are only few studies on survival outcomes. Our aim was to perform an analysis of the demographic and pathological characteristics, treatment patterns, and survival outcomes of patients affected by spiradenocarcinoma. (2) [...] Read more.
(1) Background: Spiradenocarcinoma is an extremely rare malignant adnexal tumor and there are only few studies on survival outcomes. Our aim was to perform an analysis of the demographic and pathological characteristics, treatment patterns, and survival outcomes of patients affected by spiradenocarcinoma. (2) Methods: The Surveillance, Epidemiology, and End Results program database of the National Cancer Institute was searched for all cases of spiradenocarcinoma diagnosed between 2000 and 2019. This database is considered representative of the US population. Demographic, pathological, and treatment variables were retrieved. Overall and disease-specific survival were computed according to the different variables. (3) Results: 90 cases of spiradenocarcinoma (47 females, 43 males) were identified. Mean age at diagnosis was 62.8 years. Regional and distant disease at diagnosis were rare, occurring in 2.2% and 3.3% of cases, respectively. Surgery alone was the most frequent treatment (87.8%), followed by a combination of surgery and radiotherapy (3.3%) and radiation therapy only (1.1%). Five-year overall survival was 76.2% and five-year disease-specific survival was 95.7%. (4) Conclusions: Spiradenocarcinoma equally affects males and females. Regional and distant invasion rates are low. Disease-specific mortality is low and is probably overestimated in the literature. Surgical excision remains the main form of treatment. Full article
(This article belongs to the Special Issue Clinical Advances in Plastic and Aesthetic Surgery)
►▼ Show Figures

Figure 1

16 pages, 2356 KiB  
Article
Complication Rates after Breast Surgery with the Motiva Smooth Silk Surface Silicone Gel Implants—A Systematic Review and Meta-Analysis
by Marie-Luise Aitzetmüller-Klietz, Siling Yang, Philipp Wiebringhaus, Sascha Wellenbrock, Mahmut Öztürk, Maximilian Kückelhaus, Tobias Hirsch and Matthias Michael Aitzetmüller-Klietz
J. Clin. Med. 2023, 12(5), 1881; https://doi.org/10.3390/jcm12051881 - 27 Feb 2023
Cited by 1 | Viewed by 4096
Abstract
Background: In an era where textured devices are being phased out due to concerns about BIA-ALCL, the Motiva SilkSurface breast implants intend to alleviate historical prosthesis-related complications. However, its safety and feasibility remain unelucidated. Methods: An analysis of Pubmed, Web of Science, Ovid, [...] Read more.
Background: In an era where textured devices are being phased out due to concerns about BIA-ALCL, the Motiva SilkSurface breast implants intend to alleviate historical prosthesis-related complications. However, its safety and feasibility remain unelucidated. Methods: An analysis of Pubmed, Web of Science, Ovid, and Embase databases was performed. A total of 114 studies were identified initially, and 13 of these met the inclusion criteria and were assessed regarding postoperative parameters such as complication rate or follow-up period. Results: In 4784 patients who underwent breast augmentation with Motiva SilkSurface breast implants, a total of 250 (5.2%) complications were observed. Short- and medium-term complication rates ranged from 2.8–14.4% and 0.32–16.67%, respectively. The most common complication was early seroma (n = 52, overall incidence = 1.08%), followed by early hematoma (n = 28, overall incidence = 0.54%). The incidence of capsule contracture was 0.54% and breast implant-associated-anaplastic large cell lymphoma was not observed. Discussion: Although the majority of the studies in the current literature suggest the distinction of the Motiva SilkSurface breast implants in terms of postoperative complications and capsular contracture, its safety and feasibility need to be further elucidated with well-designed, large-scale, multicenter, prospective case-control studies. Other: No funding was received. Full article
(This article belongs to the Special Issue Clinical Advances in Plastic and Aesthetic Surgery)
►▼ Show Figures

Figure 1

14 pages, 1777 KiB  
Article
Measurement of Postoperative Quality of Pain in Abdominoplasty Patients—An Outcome Oriented Prospective Study
by Sascha Wellenbrock, Matthias Michael Aitzetmüller, Marie-Luise Klietz, Philipp Wiebringhaus, Gabriel Djedovic, Tobias Hirsch and Ulrich M. Rieger
J. Clin. Med. 2023, 12(5), 1745; https://doi.org/10.3390/jcm12051745 - 22 Feb 2023
Viewed by 1181
Abstract
(1) Background: Postoperative pain is a frequently underestimated complication significantly influencing surgical outcome and patient satisfaction. While abdominoplasty is one of the most commonly performed plastic surgery procedures, studies investigating postoperative pain are limited in current literature. (2) Methods: In this prospective study, [...] Read more.
(1) Background: Postoperative pain is a frequently underestimated complication significantly influencing surgical outcome and patient satisfaction. While abdominoplasty is one of the most commonly performed plastic surgery procedures, studies investigating postoperative pain are limited in current literature. (2) Methods: In this prospective study, 55 subjects who underwent horizontal abdominoplasty were included. Pain assessment was performed by using the standardized questionnaire of the Benchmark Quality Assurance in Postoperative Pain Management (QUIPS). Surgical, process and outcome parameters were then used for subgroup analysis. (3) Results: We found a significantly decreased minimal pain level in patients with high resection weight compared to the low resection weight group (p = 0.01 *). Additionally, Spearman correlation shows significant negative correlation between resection weight and the parameter “Minimal pain since surgery” (rs = −0.332; p = 0.013). Furthermore, average mood is impaired in the low weight resection group, indicating a statistical tendency (p = 0.06 and a Χ2 = 3.56). We found statistically significant higher maximum reported pain scores (rs = 0.271; p = 0.045) in elderly patients. Patients with shorter surgery showed a statistically significant (Χ2 = 4.61, p = 0.03) increased claim for painkillers. Moreover, “mood impairment after surgery” shows a dramatic trend to be enhanced in the group with shorter OP duration (Χ2 = 3.56, p = 0.06). (4) Conclusions: While QUIPS has proven to be a useful tool for the evaluation of postoperative pain therapy after abdominoplasty, only continuous re-evaluation of pain therapy is a prerequisite for constant improvement of postoperative pain management and may be the first approach to develop a procedure-specific pain guideline for abdominoplasty. Despite a high satisfaction score, we detected a subpopulation with inadequate pain management in elderly patients, patients with low resection weight and a short duration of surgery. Full article
(This article belongs to the Special Issue Clinical Advances in Plastic and Aesthetic Surgery)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop